Changping Li

机构：Tianjin Medical University · ORCID：0000-0003-2657-8532

发表论文 91 篇 · 总被引 3030 次 · h-index 19

代表论文

• Empagliflozin alleviates atherosclerotic calcification by inhibiting osteogenic differentiation of vascular smooth muscle cells (2023 · Frontiers in Pharmacology · 被引 20)
• Significant insights from a National survey in China: PrEP awareness, willingness, uptake, and adherence among YMSM students (2024 · BMC Public Health · 被引 13)
• Effects of Helicobacter pylori and Moluodan on the Wnt/β-catenin signaling pathway in mice with precancerous gastric cancer lesions (2024 · World Journal of Gastrointestinal Oncology · 被引 12)
• Phase 2 Study of Preoperative Tislelizumab in Combination with Low-dose Nab-Paclitaxel in Patients with Muscle-invasive Bladder Cancer (2024 · European Urology Oncology · 被引 10)
• Associations between cardiovascular-kidney-metabolic syndrome and disability in activities of daily living: a nationwide longitudinal study among the middle-aged and older adults in China (2025 · Frontiers in Public Health · 被引 9)
• Cascade analysis of awareness, willingness, uptake and adherence with regard to PrEP among young men who have sex with men ( YMSM ) in China: A comparison between students and non‐students (2024 · HIV Medicine · 被引 7)